RxDoctor Payments Data

Cathy Messinger, APRN

Nurse Practitioner · Olathe, KSNPI 1801090014

Payments from drug & device makers

$3,813in general payments, 2019–2025

Across 115 payments — averaging $33.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Biosense Webster, Inc.$500
  • Boston Scientific$481
  • Kestra Medical Technology Services, Inc.$286
  • AstraZeneca$230
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$145
  • plus $506 from 12 others

What the payments were for

  • Food & beverage$3,78299%
  • Education$321%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,813 in reported general payments places this provider in the 90th percentile of 1,326 nurse practitioner providers in Kansas.

See all nurse practitioner providers in Kansas

Medicare billing

Part B allowed, 2024
$70,640
Medicare patients
421
Services billed
1,057

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban367$337,595
XareltoRivaroxaban86$86,854
Dofetilide249$33,538
Flecainide Acetate74$3,250
Diltiazem 24hr Er (Cd)Diltiazem Hcl128$3,095
Dabigatran EtexilateDabigatran Etexilate Mesylate11$2,469
SotalolSotalol Hcl141$2,340
Metoprolol Succinate210$1,844
Potassium Chloride53$958
Amiodarone Hcl64$718
Mexiletine Hcl11$663
ClopidogrelClopidogrel Bisulfate93$588
Cartia XtDiltiazem Hcl20$587
Carvedilol34$526
Losartan Potassium51$448

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$12$337,595367 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,326 nurse practitioner providers in Kansas.

Other nurse practitioner in Olathe

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →